|
|
|
Insider
Information: |
Enright Patrick G |
Relationship: |
10% Owner |
City: |
Burlingame |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
16 |
|
Direct
Shares |
3,308,185 |
|
Indirect Shares
|
27,432,603 |
|
|
Direct
Value |
$10,796,077 |
|
|
Indirect Value
|
$115,153,143 |
|
|
Total
Shares |
30,740,788 |
|
|
Total
Value |
$125,949,221 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
1
|
Stock
price went up :
|
5
|
1
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
5.0
|
1.0
|
Percentage
Gain/Loss : |
95.0%
|
101.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Molecular Templates, Inc. |
MTEM |
Director |
2006-04-20 |
496 |
2007-03-01 |
0 |
Premium* |
|
Sequenom Inc |
SQNM |
Director |
2006-12-07 |
771 |
2006-12-07 |
3,333,333 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2017-03-16 |
272,281 |
2017-03-16 |
114,675 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
20,946 |
2022-08-08 |
2,000 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
0 |
2015-03-19 |
18,361 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
10% Owner |
2015-05-12 |
0 |
2015-05-12 |
65,270 |
Premium* |
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
Aptinyx Inc. |
APTX |
Director |
2020-01-10 |
95,000 |
2020-01-10 |
3,356,746 |
Premium* |
|
Tricida, Inc. |
TCDA |
|
2018-07-02 |
0 |
2018-07-02 |
3,019,734 |
Premium* |
|
Venus Concept Inc |
VERO |
10% Owner |
|
0 |
2019-11-07 |
3,666,119 |
Premium* |
|
89bio, Inc. |
ETNB |
10% Owner |
2019-11-11 |
0 |
2020-11-16 |
891 |
Premium* |
|
Sierra Oncology Inc |
SRRA |
10% Owner |
2020-01-29 |
0 |
2022-01-25 |
1,964,771 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2022-04-19 |
4,174,379 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-04-14 |
2,918,691 |
2021-04-14 |
5,012 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
Director, 10% Owner |
2021-05-18 |
0 |
2023-02-06 |
5,144,212 |
Premium* |
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
0 |
2023-11-07 |
2,567,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ESPR |
Esperion Therapeutics, In... |
Director |
|
2015-03-19 |
4 |
S |
$110.01 |
$55,831,597 |
I/I |
(500,000) |
18,361 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-20 |
4 |
OE |
$2.77 |
$3,132,064 |
I/I |
1,130,709 |
182,742 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-20 |
4 |
S |
$5.85 |
$3,132,072 |
I/I |
(535,397) |
178,125 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-24 |
4 |
S |
$5.65 |
$3,132,066 |
I/I |
(554,348) |
13,677,121 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-24 |
4 |
OE |
$2.77 |
$3,132,064 |
I/I |
1,130,709 |
14,231,469 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-30 |
4 |
OE |
$4.05 |
$3,469,408 |
I/I |
856,644 |
194,958 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-04-06 |
4 |
S |
$168.31 |
$1,691,419 |
I/I |
(10,000) |
6,286 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-06-01 |
4 |
S |
$177.82 |
$1,787,336 |
I/I |
(10,000) |
5,893 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-07-06 |
4 |
S |
$175.81 |
$1,771,055 |
I/I |
(10,000) |
5,696 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,310 |
2,960 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-10 |
4 |
AS |
$179.98 |
$144,178 |
D/D |
(801) |
2,159 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-10 |
4 |
AS |
$180.05 |
$1,820,177 |
I/I |
(10,000) |
5,500 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
Director |
|
2015-08-11 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
7,434,630 |
2.25 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
Director |
|
2015-08-11 |
4 |
A |
$0.00 |
$0 |
I/I |
7,122,130 |
7,122,130 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-27 |
4 |
S |
$167.87 |
$71,345 |
D/D |
(425) |
1,734 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-09-01 |
4 |
S |
$164.50 |
$1,659,852 |
I/I |
(10,000) |
5,304 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-10-05 |
4 |
S |
$132.26 |
$1,337,860 |
I/I |
(10,000) |
5,108 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-11-10 |
4 |
S |
$128.96 |
$1,352,862 |
I/I |
(10,000) |
4,912 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-12-01 |
4 |
S |
$145.96 |
$1,465,910 |
I/I |
(10,000) |
4,716 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-12-02 |
4 |
S |
$148.49 |
$62,960 |
D/D |
(424) |
1,310 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-01-05 |
4 |
S |
$137.71 |
$1,380,890 |
I/I |
(10,000) |
4,519 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-02-10 |
4 |
S |
$114.43 |
$1,179,214 |
I/I |
(10,000) |
4,323 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
Director |
|
2016-03-29 |
4 |
B |
$13.50 |
$1,089,135 |
I/I |
78,504 |
7,513,134 |
2.25 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,365 |
2,675 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-08-15 |
4 |
S |
$136.45 |
$86,373 |
D/D |
(633) |
2,042 |
0 |
- |
|
169 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|